Why the study?
Although blood speckle tracking echocardiography provides hemodynamic information beyond conventional Doppler in fetuses, neonates, and children with CHD, its reproducibility, standardized reference values, and clinical validity remain incompletely established.
Does blood speckle tracking echocardiography improve hemodynamic assessment and provide incremental pathophysiological or prognostic information compared to conventional Doppler echocardiography in fetuses, neonates, and children with congenital heart disease?
Does blood speckle tracking echocardiography improve hemodynamic assessment and provide incremental pathophysiological or prognostic information compared to conventional Doppler echocardiography in fetuses, neonates, and children with congenital heart disease?
Answers are grounded in this paper and cite their sources.
Blood speckle tracking echocardiography shows high feasibility (>90% acquisition rates in several cohorts) for evaluating complex hemodynamics in pediatric and fetal congenital heart disease, though clinical validity and standardized reference values remain to be established.
Blood speckle tracking (BST) echocardiography is an emerging ultrafast ultrasound-based imaging technique that enables visualization of blood-flow patterns in cardiac chambers and great vessels. In the studies reviewed here, acquisition and flow tracking are predominantly performed in two-dimensional imaging planes and across time; therefore, the term “4D” should not be interpreted as a validated, fully volumetric three-dimensional flow acquisition. By exploiting high-frame-rate plane-wave imaging, BST allows angle-independent reconstruction of multidirectional flow vectors, vortex formation, turbulent propagation, and flow energetics, providing hemodynamic information beyond that obtainable with conventional Doppler echocardiography. This capability is particularly relevant in fetuses, neonates, and children with congenital heart disease (CHD), in whom altered chamber geometry, abnormal loading conditions, and complex postoperative anatomies frequently generate non-laminar flow patterns, recirculation zones, and pathological vortices. Over the last few years, studies have reported high feasibility of BST in selected pediatric and fetal populations, with successful acquisition rates exceeding 90% in several cohorts. However, feasibility estimates vary by study, population, imaging plane, and endpoint, and reproducibility and clinical validity remain incompletely established. Current applications include assessment of ventricular vortex morphology, energy loss, intraventricular pressure differences, aortic and pulmonary flow patterns, and characterization of altered hemodynamics in complex CHD, including bicuspid aortic valve disease, tetralogy of Fallot, coarctation of the aorta, cardiomyopathies, and single ventricle physiology. Early studies suggest that BST-derived parameters, such as vorticity, kinetic energy, vector complexity, and pressure gradients, may provide incremental pathophysiological and potentially prognostic information beyond conventional echocardiographic metrics. Despite its promising clinical potential, widespread implementation of BST remains limited by restricted software availability, limited penetration depth, lack of standardized quantitative reference values, and the still limited evidence regarding its diagnostic and prognostic superiority over standard imaging techniques. This review provides an up-to-date overview of the technical principles, current clinical applications, hemodynamic insights, and future perspectives of BST echocardiography in congenital heart disease.
No takes yet. Share an insight, caveat, or question.
Cantinotti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: